To identify combinations of compounds that synergistically inhibit the growth of human leukemia cells we performed a small molecule screen by combining the BCL2 inhibitor, ABT-737 with 1280 drugs in the library of pharmacologically active compounds (LOPAC1280). The gene discussed is BCL2; the disease is leukemia.